Melanoma associated with the use of melanotan-II.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Melanoma associated with the use of melanotan-II.
- Published In:
- Dermatology (Basel, Switzerland), 228(1), 34-6 (2014)
- Database ID:
- RPEP-02407
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02407APA
Hjuler, Kasper Fjellhaugen; Lorentzen, Henrik Frank. (2014). Melanoma associated with the use of melanotan-II.. Dermatology (Basel, Switzerland), 228(1), 34-6. https://doi.org/10.1159/000356389
MLA
Hjuler, Kasper Fjellhaugen, et al. "Melanoma associated with the use of melanotan-II.." Dermatology (Basel, 2014. https://doi.org/10.1159/000356389
RethinkPeptides
RethinkPeptides Research Database. "Melanoma associated with the use of melanotan-II." RPEP-02407. Retrieved from https://rethinkpeptides.com/research/hjuler-2014-melanoma-associated-with-the
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.